期刊文献+
共找到6篇文章
< 1 >
每页显示 20 50 100
科学家锁定癌症治疗新型药物靶点
1
作者 潘雄 《功能材料信息》 2008年第Z1期103-103,共1页
据媒体报道,美国哈佛大学科学家近日宣布,他们成功找到了治疗包括前列腺癌在内的多种癌症的新型药物靶点——活性素B,并将之描述为癌症抑制基因PTEN缺失的"动力工厂",确认活性素B在癌症的发生、发展中扮演着重要的角色。
关键词 药物靶点 科学家 癌症患者 活性 癌症治疗 癌症抑制基因 新型 缺失 家族 突变
下载PDF
有效的肿瘤生长
2
作者 杨哲 《国外医学情报》 1989年第18期12-12,共1页
肿瘤有效生长取决于血管生成过程,但这些过程之间的相互关系仍不清楚。然而,Folkman等明确证实刺激肿瘤生长因子的存在和血管生成之间的相互关系。此外,Rastinejad等发现了一种过去未知的血管生成抑制因子,当细胞能表达一种活性癌症抑... 肿瘤有效生长取决于血管生成过程,但这些过程之间的相互关系仍不清楚。然而,Folkman等明确证实刺激肿瘤生长因子的存在和血管生成之间的相互关系。此外,Rastinejad等发现了一种过去未知的血管生成抑制因子,当细胞能表达一种活性癌症抑制基因时,似乎产生上述抑制因子。此抑制因子活性的丧失与血管生成和肿瘤发生的表达同时出现。 Folkmam等在本期《Nature》杂志上报告了他们的研究结果。他们检查了通过遗传工程在胰岛β细胞中表达肿瘤基因的小鼠。结果。 展开更多
关键词 血管生成抑制因子 肿瘤生长因子 相互关系 肿瘤发生 肿瘤基因 癌症抑制基因 肿瘤形成 细胞表达 胰岛 细胞转化
下载PDF
Loss of heterozygosity on 10q23.3 and mutation of tumor suppressor gene PTEN in gastric cancer and precancerous lesions 被引量:34
3
作者 Yi-LingLi ZhongTian +2 位作者 Dong-YingWu Bao-YuFu YahXin 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第2期285-288,共4页
AIM: To investigate the loss of heterozygosity (LOH) and mutation of tumor suppressor gene PTEN in gastric cancer and precancerous lesions. METHODS: Thirty cases of normal gastric mucosa, advanced and early stage gast... AIM: To investigate the loss of heterozygosity (LOH) and mutation of tumor suppressor gene PTEN in gastric cancer and precancerous lesions. METHODS: Thirty cases of normal gastric mucosa, advanced and early stage gastric cancer, intestinal metaplasia, atrophic gastritis, and atypical hyperplasia were analyzed for PTEN LOH and mutations within the entire coding region of PTEN gene by PCR-SSCP denaturing PAGE gel electrophoresis, and PTEN mutation was detected by PCR-SSCP sequencing followed by silver staining. RESULTS: LOH rate found in respectively atrophic gastritis was 10% (3/30), intestinal metaplasia 10% (3/30), atypical hyperplasia 13.3% (4/30), early stage gastric cancer 20% (6/30), and advanced stage gastric cancer 33.3% (9/30), None of the precancerous lesions and early stage gastric cancer showed PTEN mutations, but 10% (3/30) of the advanced stage gastric cancers, which were all positive for LOH, showed PTEN mutation. CONCLUSION: LOH of PTEN gene appears in precancerous lesions, and PTEN mutations are restricted to advanced gastric cancer, LOH and mutation of PTEN gene are closely related to the infiltration and metastasis of gastric cancer. 展开更多
关键词 Gastric cancer Precancerous lesions PTEN gene Loss of heterozygosity MUTATION
下载PDF
Review:Mechanisms of inherited cancer susceptibility 被引量:1
4
作者 Shirley HODGSON 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2008年第1期1-4,共4页
A small proportion of many cancers are due to inherited mutations in genes,which result in a high risk to the indi-vidual of developing specific cancers. There are several classes of genes that may be involved: tumour... A small proportion of many cancers are due to inherited mutations in genes,which result in a high risk to the indi-vidual of developing specific cancers. There are several classes of genes that may be involved: tumour suppressor genes,onco-genes,genes encoding proteins involved in DNA repair and cell cycle control,and genes involved in stimulating the angiogenic pathway. Alterations in susceptibility to cancer may also be due to variations in genes involved in carcinogen metabolism. This review discusses examples of some of these genes and the associated clinical conditions caused by the inheritance of mutations in such genes. 展开更多
关键词 CANCER Inherited mutations DNA repair Tumour suppressor gene ONCOGENES
下载PDF
Human cancer genetics
5
作者 LI Marilyn ALBERTSON Donna 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2006年第2期164-164,共1页
The short report will be focused on the genetic basis and possible mechanisms of tumorigenesis, common types of cancer, the importance of genetic diagnosis of cancer, and the methodology of cancer genetic diagnosis. T... The short report will be focused on the genetic basis and possible mechanisms of tumorigenesis, common types of cancer, the importance of genetic diagnosis of cancer, and the methodology of cancer genetic diagnosis. They will also review presymptomatic testing of hereditary cancers, and the application of expression profiling to identify patients likely to benefit from particular therapeutic approaches. 展开更多
关键词 Cancer genetics ONCOGENES Tumor suppress genes Microarray CGH (comparative genomic hybridization) Presymptomatic testing
下载PDF
The p53/miR-34 axis in development and disease 被引量:29
6
作者 Matjaz Rokavec Huihui Li +1 位作者 Longchang Jiang and Heiko Hermeking 《Journal of Molecular Cell Biology》 SCIE CAS CSCD 2014年第3期214-230,共17页
The tumor suppressor p53 is one of the most frequently mutated genes in human cancers. MicroRNAs (miRNAs) are small non-protein coding RNAs that regulate gene expression on the post-transcriptional level. Recently, ... The tumor suppressor p53 is one of the most frequently mutated genes in human cancers. MicroRNAs (miRNAs) are small non-protein coding RNAs that regulate gene expression on the post-transcriptional level. Recently, it was shown that p53 regulates the expression of several miRNAs, thereby representing an important mechanism of p53 signaling. Several independent studies identified the members of the miR-34 family as the most prevalent p53-induced miRNAs, miR-34s are frequently silenced in variety of tumor entities, suggesting that they are important tumor suppressors. Indeed, ectopic expression of miR-34s inhibits proliferation, epithelial to mes- enchymat transition, migration, invasion, and metastasis of various cancer celt entities. Moreover, delivery or re-expression of miR-34 leads to notable repression of tumor growth and metastasis in cancer mouse models, and may therefore represent an efficient strategy for future cancer therapeutics. Besides their crucial functions in cancer, members of the miR-34 family also play important roles in spermatogenesis, stem cell differentiation, neuronal development, aging, and cardiovascular functions. Consequently, miR-34 has also been implicated in various non-cancerous diseases, such as brain disorders, osteoporosis, and cardiovascular complications. 展开更多
关键词 P53 miR-34 MIR-34A miR-34b/c CANCER METASTASIS tumor suppression
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部